Keywords: Ligand, Merck & Co, Captisol, Supply deal

Ligand in commercial supply deal with Merck & Co for Captisol

Article | 21 June 2011

Print This

USA-based Ligand Pharmaceuticals (Nasdaq: LGND) has entered into a Captisol supply agreement with drugs giant Merck & Co (NYSE: MRK) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in